Plain-English translation of NCT05520762 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When a patient's heart stops beating in the hospital, doctors need to quickly secure their airway to help them breathe. This trial is testing whether a simpler airway device (called a supraglottic airway) works as well as or better than a more complex procedure (endotracheal intubation) during these life-threatening emergencies. The trial will compare how well each approach works in real hospital settings with diverse patient populations.
Most guidance on airway management during cardiac arrest comes from studies of people who had heart attacks outside the hospital, but hospital patients are often different—they're older, sicker, and already being cared for by trained medical teams. Research from out-of-hospital emergencies suggests the simpler airway device might work just as well or even better, but no one has tested this idea yet in hospitals, so doctors need this trial to know which approach to use.
You likely qualify if…
You likely don't qualify if…
If your heart stops while you're in the hospital, the medical team will use one of the two airway methods being tested as part of their emergency treatment. You won't need to do anything special—the doctors will manage your care as they normally would, but they'll use whichever airway approach their hospital is testing that month. The study involves four hospitals in the New York City area that switch between the two methods monthly.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States
Sponsor
Montefiore Medical Center
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment target
~1,060 participants
Started
February 2023
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ari Moskowitz, MD
Montefiore Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.